Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
3.250
+0.110 (3.50%)
Nov 9, 2026, 4:00 PM EST - Market closed
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $565.25 million as of November 9, 2026. It is the 13,557th most valuable company in the world and the 2,635th biggest in the United States. Its market cap has increased by 294.18% in one year.
Market Cap
565.25M
Enterprise Value
299.76M
1-Year Change
294.18%
Global Rank
Country Rank
#2,635 United States
Category
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $565.25M, an increase of 691.66%. That is a compound annual growth rate of 28.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 565.25M | 535.11% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 591.51M |
| Capricor Therapeutics | 572.67M |
| Valneva SE | 566.64M |
| SL Science Holding | 562.11M |
| Surrozen | 561.94M |
| Ovid Therapeutics | 555.62M |
| REGENXBIO | 534.60M |
| Neurogene | 521.10M |